Related Experiment Videos
[A clinical analysis of cutaneous type dermatomyositis]
B Yu1
1PUMC Hospital, CAMS, Beijing.
Summary
Dermatomyositis can present with skin symptoms alone, without muscle involvement, for at least two years. This "cutaneous dermatomyositis" subtype is distinct and responds well to prednisone treatment.
Area of Science:
- Dermatology
- Rheumatology
- Immunology
Context:
- Dermatomyositis is an idiopathic inflammatory myopathy.
- Cutaneous manifestations are key diagnostic features.
- A subset of patients may not develop muscle disease.
Purpose:
- To characterize patients with dermatomyositis presenting solely with cutaneous findings.
- To evaluate the long-term prognosis and treatment response in this patient group.
- To propose refined terminology for this clinical presentation.
Summary:
- Nine patients with classic dermatomyositis skin findings showed no muscle disease for over two years.
- These cases represented 3.5% of the total dermatomyositis patient cohort.
- Five patients improved significantly with oral prednisone treatment for skin lesions or mild myositis.
- No patients exhibited evidence of malignancy.
- The study advocates for the term 'cutaneous dermatomyositis' over 'amyopathic dermatomyositis'.
Impact:
- Highlights a distinct subtype of dermatomyositis, emphasizing skin findings.
- Suggests 'cutaneous dermatomyositis' as a more accurate descriptor.
- Demonstrates the efficacy of prednisone in managing cutaneous symptoms.